Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1Eric L. Logigian, Michael McDermott, Nuran Dilek et al.|Neurology|2010Cited by 198
FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical modelsTimothy Weeden, Stefano Zanotti, Tyler Picariello et al.|Communications Medicine|2025Cited by 25